At the beginning of the February, Johnson & Johnson Vision, a global leader in eye health, announced that the FDA approved the TECNIS EyhanceTM and TECNIS EyhanceTM Toric II intraocular lens (IOL) for the treatment of cataract patients in the United States. Dr. Farhan Irshad and the Eye Clinic of Austin team were the first […]
Just a few months ago, Alcon, a leader in global eye care, announced the launch of a new and innovative intraocular lens (IOL) called AcrySof® IQ Vivity®. The Vivity lens is a first-of-its-kind and first unrolled in Europe in early 2020 following in North America only recently. During this time, the Eye Clinic of Austin’s […]
The FDA has approved AcrySof IQ PanOptix Trifocal IOL, the first and only trifocal lens authorized for patients undergoing cataract surgery.
Farhan A. Irshad, MD FACS and the Eye Clinic of Austin team are excited to announce the arrival of an innovative new procedure for Glaucoma patients – the iStent inject®.
Congenital cataracts (or cataracts present from birth), like cataracts that come with age, are currently treated by surgery – the removal of the lens and implanting an artificial lens in its place.
The newest cataract surgery advancement, Dropless Cataract Surgery™, is now available at Eye Clinic of Austin. Dropless Cataract Surgery is a new treatment option that reduces or eliminates the need for patients to administer pricey prescription eye drops 3-4 weeks after the surgery.